an R package to compare the genetic/epigenetic features between cancer cell lines with different dependencies of a gene set (signature)
‘deplink’ compares the genetic/epigenetic features between cancer cell lines with different dependencies of a gene set (signature).
Data source: DepMap (release 2019q4) and CCLE
For details, please see Tutorial.
library(devtools)
install_github("seanchen607/deplink")
library(deplink)
source(system.file("script", "load_libs.R", package = "deplink"))
For example, deplink compares the genetic/epigenetic features between cancer cell lines with highest and lowest dependencies of "9-1-1" complex members:
deplink(signature.name = "9-1-1", signature = c("RAD9A", "RAD1", "HUS1", "RAD17"))
The results will be output to a local directory (default: root directory) under a folder in name of the designated "signature.name" ("9-1-1" in this case).
Several cutoffs are set by default as below and can be changed by will. Please see the help page for more details (?deplink).
cutoff.freq = 10
cutoff.percentile = 0.2
cutoff.pvalue = 0.05
cutoff.qvalue = 0.1
cutoff.diff = 0.1
cutoff.fc = 2
The comparison covers the following features:
-
Genomic/epigenetic features
- Genetic dependency
- Gene expression
- Chromatin modification
-
Genome instability
- Genetic mutation
- COSMIC signature
- Tumor mutation burden (TMB)
- Copy number variation (CNV)
- Microsatellite instability (MSI)
-
Drug sensitivity
- Drug sensitivity from GDSC data set
- Drug sensitivity from PRISM data set
-
Immune infiltration
- Immune signature gene (ISG)
-
Stemness
- mRNA stemness index (mRNAsi)
- Epithelial–mesenchymal transition (EMT)
-
Misc.
- Cancer type
- Hallmark signature
Xiao CHEN, PhD
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York
https://www.researchgate.net/profile/Xiao_Chen126
If you use deplink in published research, please cite the most appropriate paper(s) from this list:
- X Chen, J McGuire, F Zhu, X Xu, Y Li, D Karagiannis, R Dalla-Favera, A Ciccia, J Amengual & C Lu (2020). Harnessing genetic dependency correlation network to reveal chromatin vulnerability in cancer. In preparation.